surgical implantation

DEVICE2 trials

Sponsors

Neuralstem Inc., NYU Langone Health

Conditions

Amputation; Lower ExtremityAmyotrophic Lateral SclerosisPain, Persistent Postsurgical

Phase 1

Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

Neuralstem Inc.Amyotrophic Lateral Sclerosis

Start: 2009-01-31End: 2016-12-31Target: 18Updated: 2016-03-10

Unknown Phase

Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI

Not yet recruitingNCT07571239

NYU Langone HealthAmputation; Lower Extremity, Pain, Persistent Postsurgical

Start: 2026-07-01End: 2028-07-01Target: 32Updated: 2026-05-06

Related Papers

Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial

Nature Medicine2022-09-01141 citations